{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:10:39Z","timestamp":1763727039837,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":2632,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["P30MH092177"],"award-info":[{"award-number":["P30MH092177"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS087971"],"award-info":[{"award-number":["R01NS087971"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13311-016-0439-1","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T10:36:57Z","timestamp":1462444617000},"page":"547-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene Editing for Treatment of Neurological Infections"],"prefix":"10.1016","volume":"13","author":[{"given":"Martyn K.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassen","family":"Wollebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-016-0439-1_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13550289509111005","article-title":"Neurovirology: evolution of a new discipline","volume":"1","author":"Johnson","year":"1995","journal-title":"J Neurovirol"},{"key":"10.1007\/s13311-016-0439-1_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus infections in the nervous system","volume":"13","author":"Koyuncu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1007\/s13311-016-0439-1_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2741\/1830","article-title":"HIV disorders of the brain: pathology and pathogenesis","volume":"11","author":"Del Valle","year":"2006","journal-title":"Front Biosci"},{"key":"10.1007\/s13311-016-0439-1_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fvl.12.57","article-title":"Neuronal toxicity in HIV CNS disease","volume":"7","author":"Kovalevich","year":"2012","journal-title":"Future Virol"},{"issue":"Suppl 2","key":"10.1007\/s13311-016-0439-1_bib5","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.78.s2.03","article-title":"The clinical features of PML","volume":"78","author":"Berger","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1007\/s13311-016-0439-1_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/rmv.710","article-title":"Progressive multifocal leukoencephalopathy: clinical and molecular aspects","volume":"22","author":"Tavazzi","year":"2012","journal-title":"Rev Med Virol"},{"key":"10.1007\/s13311-016-0439-1_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","article-title":"Persistence and pathogenesis of the neurotropic polyomavirus JC","volume":"77","author":"Wollebo","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-016-0439-1_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jiq097","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy\u2014revisited","volume":"203","author":"White","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1007\/s13311-016-0439-1_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09540260701862037","article-title":"The neuropathology of HIV\/AIDS","volume":"20","author":"Anthony","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1007\/s13311-016-0439-1_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13365-015-0346-y","article-title":"Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment","volume":"21","author":"Rappaport","year":"2015","journal-title":"J Neurovirol"},{"key":"10.1007\/s13311-016-0439-1_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136046","article-title":"CRISPR\/Cas9 System as an agent for eliminating polyomavirus JC infection","volume":"10","author":"Wollebo","year":"2015","journal-title":"PLoS One"},{"key":"10.1007\/s13311-016-0439-1_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s13365-014-0308-9","article-title":"Genome editing strategies: potential tools for eradicating HIV-1\/AIDS","volume":"21","author":"Khalili","year":"2015","journal-title":"J Neurovirol"},{"key":"10.1007\/s13311-016-0439-1_bib13","doi-asserted-by":"crossref","unstructured":"Pires de Mello CP, Bloom DC, Paix\u00e3o IC. Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets. Antivir Ther 2016 Jan 4 [Epub ahead of print].","DOI":"10.3851\/IMP3018"},{"key":"10.1007\/s13311-016-0439-1_bib14","unstructured":"Berger A, Shahar T, Margalit N. Post-craniotomy herpes simplex type 2 encephalitis: case report and literature review. World Neurosurg 2015;pii:S1878-8750(15)01724-6."},{"key":"10.1007\/s13311-016-0439-1_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0046-8177(87)80012-6","article-title":"Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature","volume":"18","author":"Morgello","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1007\/s13311-016-0439-1_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13550280290049723","article-title":"Central nervous system infections in individuals with HIV-1 infection","volume":"8","author":"Mamidi","year":"2002","journal-title":"J Neurovirol"},{"key":"10.1007\/s13311-016-0439-1_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcv.2013.03.017","article-title":"Adenovirus infection associated with central nervous system dysfunction in children","volume":"57","author":"Huang","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1007\/s13311-016-0439-1_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system\u2014prognosis, diagnostics and treatment","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"key":"10.1007\/s13311-016-0439-1_bib19","doi-asserted-by":"crossref","unstructured":"White MK, Khalili K. CRISPR\/Cas9 and cancer targets: future possibilities and present challenges. Oncotarget 2016 Jan 31 [Epub ahead of print].","DOI":"10.18632\/oncotarget.7104"},{"key":"10.1007\/s13311-016-0439-1_bib20","first-page":"255","article-title":"The CRISPR\/Cas9 genome editing methodology as a weapon against human viruses","volume":"19","author":"White","year":"2015","journal-title":"Discov Med"},{"key":"10.1007\/s13311-016-0439-1_bib21","doi-asserted-by":"crossref","first-page":"31978","DOI":"10.1016\/S0021-9258(18)31791-5","article-title":"Insertion and deletion mutants of FokI restriction endonuclease","volume":"269","author":"Kim","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-016-0439-1_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nmeth.2030","article-title":"Targeted gene knockout by direct delivery of zinc-finger nuclease proteins","volume":"9","author":"Gaj","year":"2012","journal-title":"Nat Methods"},{"key":"10.1007\/s13311-016-0439-1_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-016-0439-1_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20140295","article-title":"TALEN-mediated genome editing: prospects and perspectives","volume":"462","author":"Wright","year":"2014","journal-title":"Biochem J"},{"key":"10.1007\/s13311-016-0439-1_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-2932-0_3","article-title":"The development of TALE nucleases for biotechnology","volume":"1338","author":"Ousterout","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1007\/s13311-016-0439-1_bib26","doi-asserted-by":"crossref","unstructured":"Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014;346:1258096.","DOI":"10.1126\/science.1258096"},{"key":"10.1007\/s13311-016-0439-1_bib27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1007\/s13311-016-0439-1_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nmeth.3684","article-title":"Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery","volume":"13","author":"Bolukbasi","year":"2015","journal-title":"Nat Methods"},{"key":"10.1007\/s13311-016-0439-1_bib29","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1007\/s13311-016-0439-1_bib30","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1007\/s13311-016-0439-1_bib31","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1007\/s13311-016-0439-1_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","article-title":"CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation","volume":"45","author":"Bhaya","year":"2011","journal-title":"Annu Rev Genet"},{"key":"10.1007\/s13311-016-0439-1_bib33","doi-asserted-by":"crossref","first-page":"21312","DOI":"10.1074\/jbc.M114.564625","article-title":"Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)\/Cas9 nuclease system in mammalian cells","volume":"289","author":"Canver","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-016-0439-1_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1007\/s13311-016-0439-1_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molcel.2015.10.008","article-title":"Discovery and functional characterization of diverse class 2 CRISPR-Cas systems","volume":"60","author":"Shmakov","year":"2015","journal-title":"Mol Cell"},{"key":"10.1007\/s13311-016-0439-1_bib36","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-016-0439-1_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1007\/s13311-016-0439-1_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1007\/s13311-016-0439-1_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11904-015-0257-9","article-title":"The potential of the CNS as a reservoir for HIV-1 infection: Implications for HIV eradication","volume":"12","author":"Fois","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1007\/s13311-016-0439-1_bib40","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-016-0439-1_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-016-0439-1_bib42","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","volume":"6","author":"Liao","year":"2015","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-016-0439-1_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1007\/s13311-016-0439-1_bib44","doi-asserted-by":"crossref","first-page":"16277","DOI":"10.1038\/srep16277","article-title":"CRISPR\/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-016-0439-1_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/mt.2015.213","article-title":"CRISPR-mediated activation of latent HIV-1 expression","volume":"24","author":"Limsirichai","year":"2016","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-016-0439-1_bib46","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/mt.2015.202","article-title":"Potent and targeted activation of latent HIV-1 using the CRISPR\/dCas9 activator complex","volume":"24","author":"Saayman","year":"2016","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-016-0439-1_bib47","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/v5112748","article-title":"Newer gene editing technologies toward HIV gene therapy","volume":"5","author":"Manjunath","year":"2013","journal-title":"Viruses"},{"key":"10.1007\/s13311-016-0439-1_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/COH.0b013e32835f736c","article-title":"Targeted gene disruption to cure HIV","volume":"8","author":"Stone","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1007\/s13311-016-0439-1_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115987","article-title":"CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1007\/s13311-016-0439-1_bib50","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1038\/srep15577","article-title":"Genome editing of CXCR4 by CRISPR\/cas9 confers cells resistant to HIV-1 infection","volume":"5","author":"Hou","year":"2015","journal-title":"Sci Rep."},{"key":"10.1007\/s13311-016-0439-1_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.42","article-title":"CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus","volume":"4","author":"Kang","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1007\/s13311-016-0439-1_bib52","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","article-title":"Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"1","author":"Padgett","year":"1971","journal-title":"Lancet"},{"key":"10.1007\/s13311-016-0439-1_bib53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/jvi.51.2.458-469.1984","article-title":"Human polyomavirus JC virus genome","volume":"51","author":"Frisque","year":"1984","journal-title":"J Virol"},{"key":"10.1007\/s13311-016-0439-1_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2004.03.025","article-title":"Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis","volume":"324","author":"White","year":"2004","journal-title":"Virology"},{"key":"10.1007\/s13311-016-0439-1_bib55","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1038\/sj.onc.1209618","article-title":"Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses","volume":"25","author":"White","year":"2006","journal-title":"Oncogene"},{"key":"10.1007\/s13311-016-0439-1_bib56","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1128\/JVI.75.18.8803-8817.2001","article-title":"U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids","volume":"75","author":"Reynolds","year":"2001","journal-title":"J Virol"},{"key":"10.1007\/s13311-016-0439-1_bib57","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1128\/JVI.76.17.8939-8952.2002","article-title":"Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids","volume":"76","author":"Reynolds","year":"2002","journal-title":"J Virol"},{"key":"10.1007\/s13311-016-0439-1_bib58","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1128\/JVI.78.11.5591-5600.2004","article-title":"Herpes simplex virus 1 U(L)31 and U(L)34 gene products promote the late maturation of viral replication compartments to the nuclear periphery","volume":"78","author":"Simpson-Holley","year":"2004","journal-title":"J Virol"},{"key":"10.1007\/s13311-016-0439-1_bib59","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1128\/JVI.01143-15","article-title":"The Torsin activator LULL1 Is required for efficient growth of Herpes Simplex Virus 1","volume":"89","author":"Turner","year":"2015","journal-title":"J Virol"},{"key":"10.1007\/s13311-016-0439-1_bib60","doi-asserted-by":"crossref","first-page":"E1545","DOI":"10.1073\/pnas.1300676110","article-title":"Regulation of Torsin ATPases by LAP1 and LULL1","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-016-0439-1_bib61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1074\/jbc.M113.515791","article-title":"Arresting a Torsin ATPase reshapes the endoplasmic reticulum","volume":"289","author":"Rose","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-016-0439-1_bib62","first-page":"1096","article-title":"The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I","volume":"3","author":"Kaplan","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1007\/s13311-016-0439-1_bib63","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2013.46","article-title":"A novel therapeutic molecule against HTLV-1 infection targeting provirus","volume":"27","author":"Tanaka","year":"2013","journal-title":"Leukemia"},{"key":"10.1007\/s13311-016-0439-1_bib64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","article-title":"Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses","volume":"26","author":"Wang","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1007\/s13311-016-0439-1_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/mt.2015.164","article-title":"Engineered viruses as genome editing devices","volume":"24","author":"Chen","year":"2016","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-016-0439-1_bib66","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/hum.2015.074","article-title":"Delivery and specificity of CRISPR-Cas9 genome editing technologies for human gene therapy","volume":"26","author":"Gori","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1007\/s13311-016-0439-1_bib67","doi-asserted-by":"crossref","unstructured":"67 Li L, He ZY, Wei XW, Gao GP, Wei YQ. Challenges in CRISPR\/CAS9 Delivery: Potential Roles of Nonviral Vectors. Hum Gene Ther 2015;26:452-462.","DOI":"10.1089\/hum.2015.069"},{"key":"10.1007\/s13311-016-0439-1_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1007\/s13311-016-0439-1_bib69","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1073\/pnas.1501698112","article-title":"Rational design of a split-Cas9 enzyme complex","volume":"112","author":"Wright","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-016-0439-1_bib70","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-016-0439-1_bib71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1007\/s13311-016-0439-1_bib72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","article-title":"Viral vectors for gene delivery to the central nervous system","volume":"48","author":"Lentz","year":"2012","journal-title":"Neurobiol Dis"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-016-0439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-016-0439-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-016-0439-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-016-0439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:48:15Z","timestamp":1761806895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1878747923009224"],"URL":"https:\/\/doi.org\/10.1007\/s13311-016-0439-1","relation":{},"ISSN":["1878-7479"],"issn-type":[{"type":"print","value":"1878-7479"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Editing for Treatment of Neurological Infections","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-016-0439-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}